Morphogenesis receives FDA ‘fast track’ designation for skin cancer vaccine

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

If you’ve been following the saga of drug shortages in this publication, you know how America’s cancer institutions are scrambling to obtain platinum-based drugs for their patients.

September 29, 2023

Vol.49 No.36

By Jacquelyn Cobb

Capitol Hill

Most NIH activities will cease immediately if government shuts down

Nearly 80% of NIH staff will be furloughed if Congress fails to fund the federal government or pass a continuing resolution before midnight Saturday, Sept. 30—halting many administrative functions and nonclinical activities in the agency’s research pipelines.

September 29, 2023

Vol.49 No.36

By Matthew Bin Han Ong

Film & TV

Women physicians are underrepresented in film, a study led by oncologists finds

OK, name a movie doctor—fast!Chances are, you are thinking of Robin Williams as Patch Adams in the eponymous flick or of Harrison Ford as Dr. Richard Kimble in “The Fugitive.”

September 29, 2023

Vol.49 No.36

By Alexandria Carolan

Guest Editorial

“Oppenheimer” is a reminder to physicians, scientists to act to prevent nuclear war

Many readers of The Cancer Letter will have seen or at least be aware of the buzz surrounding release of the new “Oppenheimer” movie, which has received excellent reviews.

September 29, 2023

Vol.49 No.36

By Robert Peter Gale and Andreas Hochhaus

TCL Archive

NCI’s SEER marks 50 years of cancer surveillance

NCI’s Surveillance, Epidemiology, and End Results Program in the Division of Cancer Control and Population Sciences at NCI is marking 50 years of cancer surveillance.

September 29, 2023

Vol.49 No.36

In Brief

ARPA-H establishes health innovation network

The Advanced Research Projects Agency for Health has established ARPANET-H, a nationwide health innovation network anchored by three ARPA-H regional hubs.

September 29, 2023

Vol.49 No.36

Morphogenesis receives FDA ‘fast track’ designation for skin cancer vaccine

YOU MAY BE INTERESTED IN

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

Most NIH activities will cease immediately if government shuts down

Women physicians are underrepresented in film, a study led by oncologists finds

“Oppenheimer” is a reminder to physicians, scientists to act to prevent nuclear war

NCI’s SEER marks 50 years of cancer surveillance

ARPA-H establishes health innovation network

Renew today!

Subscriber content

Login